The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes.

Liu Y, Liu J, Ma Y, Zhang Y, Chen Q, Yang X, Shang Y

Open source

DOI
10.1080/21655979.2021.1997090
Published
2022 Jan
Container
Bioengineered
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21655979.2021.1997090,
  title = {The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes.},
  author = {Liu Y and Liu J and Ma Y and Zhang Y and Chen Q and Yang X and Shang Y},
  year = {2022},
  journal = {Bioengineered},
  doi = {10.1080/21655979.2021.1997090},
  url = {https://doi.org/10.1080/21655979.2021.1997090}
}

RIS

TY  - JOUR
TI  - The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes.
AU  - Liu Y
AU  - Liu J
AU  - Ma Y
AU  - Zhang Y
AU  - Chen Q
AU  - Yang X
AU  - Shang Y
PY  - 2022
JO  - Bioengineered
DO  - 10.1080/21655979.2021.1997090
UR  - https://doi.org/10.1080/21655979.2021.1997090
ER  - 

APA

Y, L., J, L., Y, M., Y, Z., Q, C., X, Y., & Y, S. (2022). The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes.. Bioengineered. https://doi.org/10.1080/21655979.2021.1997090

Source records